Some clinically important interactions of psychotropic drugs.
D000928:Antidepressive Agents / Q000009:adverse effects / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D004064:Digestive System / Q000187:drug effects; D004347:Drug Interactions; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D001523:Mental Disorders / Q000188:drug therapy*; D008774:Methylphenidate / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014273:Triflupromazine / Q000494:pharmacology
D000928:Antidepressive Agents; D002395:Catecholamines; D000697:Central Nervous System Stimulants; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D014149:Tranquilizing Agents; D008774:Methylphenidate; D014273:Triflupromazine; D010634:Phenobarbital